Monsanto, Stanley .

HRN: 22-06-22  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/09/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/09/2023
04/16/2023
IV
70mg
Q8hours
Acute Gastroenteritis With Severe Dehydration
Waiting Final Action 
04/09/2023
CEFUROXIME 1.5GM (VIAL)
04/09/2023
04/15/2023
IV
240
Q8H
Pneumonia
Waiting Final Action 
04/10/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/10/2023
04/16/2023
IV
90
Q24H
Sepsis
Waiting Final Action 
04/10/2023
CEFTRIAXONE 1G (VIAL)
04/10/2023
04/17/2023
IV
600mg
Q24
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: